Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2023

Nov 3, 2023

30718_dirs_2023-11-03_9050470e-6277-4404-a163-660a654afb07.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-11-01

Reporting Person: Hippel James (CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-11-01 Restricted Stock Units $ A 26318 Acquired Common Stock (26318) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 57561 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (Right to Buy) $31.26 2024-08-09 Common Stock (189156) 189156 Direct
Stock Options (Right to Buy) $44.33 2025-08-08 Common Stock (168620) 168620 Direct
Stock Options (Right to Buy) $47.60 2026-08-07 Common Stock (186068) 186068 Direct
Stock Options (Right to Buy) $66.97 2027-08-05 Common Stock (90740) 90740 Direct
Stock Options (Right to Buy) $66.97 2027-08-05 Common Stock (76588) 76588 Direct
Restricted Stock Units $ Common Stock (7780) 7780 Direct
Stock Options (Right to Buy) $120.46 2028-08-06 Common Stock (30400) 30400 Direct
Stock Options (Right to Buy) $120.46 2028-08-06 Common Stock (40536) 40536 Direct
Restricted Stock Units $ Common Stock (10912) 10912 Direct
Stock Options (Right to Buy) $94.52 2029-08-15 Common Stock (33916) 33916 Direct
Stock Options (Right to Buy) $94.52 2029-08-15 Common Stock (45220) 45220 Direct
Restricted Stock Units $ Common Stock (12798) 12798 Direct
Stock Options (Right to Buy) $84.61 2030-08-15 Common Stock (34442) 34442 Direct
Stock Options (Right to Buy) $84.61 2030-08-15 Common Stock (45923) 45923 Direct

Footnotes

F1: Fully exercisable.

F2: Options to purchase 57,440 shares are vested. Options to purchase 19,148 shares vest on 8/5/2024.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

F4: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Options to purchase 20,268 shares are vested. Options to purchase 10,136 shares vest on 8/6/2024 and options to purchase 10,134 shares vest on 8/6/2025.

F6: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F7: Options to purchase 11,304 shares are vested. Options to purchase 11,304 shares vest on each of 8/15/2025 and 8/15/2026 and options to purchase 11,308 shares vest on 8/15/2024.

F8: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F9: Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.

F10: 13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.